Effect of ostarine on glucose level, lipid profile, and osteoporosis in streptozotocin induced diabetic male rats
Canadian Journal of Physiology and Pharmacology · 01.01.2026 · 104 · 1-13
DOI: 10.1139/cjpp-2025-0063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.01.2026. Verfasst von Aml I Gadallah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physiology, Faculty of Medicine, Assiut University, Assiut, Egypt. Hauptthemen laut MEDLINE: Osteoporosis, Diabetes Mellitus, Experimental, Blood Glucose, Lipids. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Assiut Medical School Grants Office at the faculty of medicine, Assiut University, Egypt.
Abstract (Originalsprache)
This study aimed to evaluate ostarine effects on blood glucose, dyslipidemia, and osteoporosis in diabetic rats. Forty-eight adult male rats were divided into six groups (Control, Ostarine: 0.4 mg/kg daily orally, diabetes mellitus (DM), DO: diabetic rats received ostarine, DI: diabetic rats received insulin, DOI: diabetic rats received ostarine and insulin for 8 weeks). Radiographic examination for bone was done. Blood samples, bone, and pancreas were taken for examination. Ostarine significantly increased body weight, muscle weight, bone weight and ashing, lowered blood glucose, TC, low-density lipoprotein-cholesterol (LDL-C), and triglycerides, increased Ca ++ , phosphorus (P), osteocalcin, RUNX2, and positive immunostained osteopontin cells compared to DM, but no significance on CTX-I or RANKL. It improved bone density in X-ray, pancreatic islet cells and bone microarchitecture in histological examinations, being more apparent in ostarine and insulin-treated group. However, insulin alone had no significant effect on TC, LDL-C, Ca ++ , P, OC, CTX-I, RUNX2, RANKL, or osteopontin and downregulated alkaline phosphatase compared to DM, with focal decreased bone radiodensity and minimal improvement in bone and pancreatic sections. In conclusion, ostarine could have beneficial effects on diabetes such as improving glycemic state, dyslipidemia, and mainly diabetic osteoporotic bone. Ostarine should be further evaluated in diabetic osteoporosis or other types of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physiology, Faculty of Medicine, Assiut University, Assiut, Egypt.
- Department of histology, Faculty of Medicine, Assiut University, Assiut, Egypt.
- Department of Surgery, Anaesthesiology and Radiology, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt.
ORCID-Profile: Aml I Gadallah, Azza S Abdelhaffez, Sally A Sayed
Förderung
- Assiut Medical School Grants Office at the faculty of medicine, Assiut University, Egypt
Zitieren
APA
Gadallah, A., Abdelhaffez, A., Hussein, O., Sayed, S., Abdelhakiem, M., & El-Mottaleb, N. (2026). Effect of ostarine on glucose level, lipid profile, and osteoporosis in streptozotocin induced diabetic male rats. Canadian Journal of Physiology and Pharmacology, 104, 1-13. https://doi.org/10.1139/cjpp-2025-0063
Vancouver
Gadallah A, Abdelhaffez A, Hussein O, Sayed S, Abdelhakiem M, El-Mottaleb N. Effect of ostarine on glucose level, lipid profile, and osteoporosis in streptozotocin induced diabetic male rats. Canadian Journal of Physiology and Pharmacology. 2026;104:1-13. doi:10.1139/cjpp-2025-0063
BibTeX
@article{Gadallah2026,
author = {Gadallah, Aml I and Abdelhaffez, Azza S and Hussein, Ola A and Sayed, Sally A and Abdelhakiem, M A H and El-Mottaleb, Nashwa A Abd},
title = {Effect of ostarine on glucose level, lipid profile, and osteoporosis in streptozotocin induced diabetic male rats},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2026},
volume = {104},
pages = {1--13},
doi = {10.1139/cjpp-2025-0063}
}
EUVIMED